Torii Pharmaceutical
Tokyo, Japan· Est.
Japanese dermatology-focused pharmaceutical company specializing in rare skin disease treatments through small molecule and topical formulations.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Japanese dermatology-focused pharmaceutical company specializing in rare skin disease treatments through small molecule and topical formulations.
DermatologyRare Disease
Technology Platform
Specialization in topical formulation development and small molecule therapeutics for dermatological conditions, with focus on rare skin diseases.
Opportunities
Growth through expansion of dermatology portfolio, particularly in rare skin diseases, and leveraging Shionogi's resources post-merger for broader development and commercialization capabilities.
Risk Factors
Integration risks with Shionogi merger, dependence on limited dermatology portfolio, and competition in atopic dermatitis market from both topical and systemic therapies.
Competitive Landscape
Competes in specialized dermatology segments against companies like Maruho and Sato Pharmaceutical in Japan, with differentiation through rare disease focus and topical formulation expertise.